[PDF][PDF] Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren's syndrome
S Gandolfo, S De Vita - Clin Exp Rheumatol, 2019 - academia.edu
S Gandolfo, S De Vita
Clin Exp Rheumatol, 2019•academia.eduPrimary Sjögren's syndrome (pSS) is an autoimmune connective tissue disease
characterised by an enhanced lymphoproliferative status, with a greater risk of hesitating in
malignant lymphoma. The pathological hallmark of pSS is the mucosa-associated lymphoid
tissue
characterised by an enhanced lymphoproliferative status, with a greater risk of hesitating in
malignant lymphoma. The pathological hallmark of pSS is the mucosa-associated lymphoid
tissue
Abstract
Primary Sjögren’s syndrome (pSS) is an autoimmune connective tissue disease characterised by an enhanced lymphoproliferative status, with a greater risk of hesitating in malignant lymphoma. The pathological hallmark of pSS is the mucosa-associated lymphoid tissue
academia.edu
